Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model
Moritz Klawitter, Ali El-Ayoubi, Jasmin Buch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9965-9965
Open Access | Times Cited: 18

Showing 18 citing articles:

A Renaissance for Oncolytic Adenoviruses?
Paola Blanchette, Jose G. Teodoro
Viruses (2023) Vol. 15, Iss. 2, pp. 358-358
Open Access | Times Cited: 12
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
Sebastian Johannes Schober, Caroline Schoening, Jennifer Eck, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 10, pp. 1996-2011
Open Access | Times Cited: 12
Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner
Miao Zeng, Wei Zhang, Yisheng Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
In vitro and in vivo study on the treatment of non-small cell lung cancer with radionuclide labeled PD-L1 nanobody
Mengqin Zhu, Jiajia Zhang, Mengdie Yang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8429-8442
Closed Access | Times Cited: 8
Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer
Ryunosuke Hoshi, Kristyna A. Gorospe, Hagar I. Labouta, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1181-1181
Open Access | Times Cited: 2
Translational Models in Glioma Immunotherapy Research
Alexander Ren, Janet Y. Wu, Si Yeon Lee, et al.
Current Oncology (2023) Vol. 30, Iss. 6, pp. 5704-5718
Open Access | Times Cited: 7
TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model
Sebastian Johannes Schober, Melanie Thiede, Hendrik Gassmann, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
In vivo mouse models for adult brain tumors: Exploring tumorigenesis and advancing immunotherapy development
John Figg, Dongjiang Chen, Laura Falceto Font, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 11, pp. 1964-1980
Closed Access | Times Cited: 1
The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockade
Sajad Najafi, Jamal Majidpoor, Keywan Mortezaee
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114436-114436
Open Access | Times Cited: 4
Intranasal Delivery of Oncolytic Adenovirus XVir-N-31 via Optimized Shuttle Cells Significantly Extends Survival of Glioblastoma-Bearing Mice
Ali El-Ayoubi, Moritz Klawitter, Jakob Rüttinger, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4912-4912
Open Access | Times Cited: 4
Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system
Ali El-Ayoubi, Arsen Arakelyan, Moritz Klawitter, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Development of an optimized, non‐stem cell line for intranasal delivery of therapeutic cargo to the central nervous system
Ali El‐Ayoubi, Arsen Arakelyan, Moritz Klawitter, et al.
Molecular Oncology (2023)
Open Access | Times Cited: 2
YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells
Anna Josefine von Ofen, Uwe Thiel, Jennifer Eck, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
溶瘤病毒助力肿瘤免疫治疗
Yujie Yang, Yian Wang, Jie Wu, et al.
Scientia Sinica Vitae (2024) Vol. 54, Iss. 11, pp. 2037-2050
Closed Access
YBX1: A Multifunctional Protein in Senescence and Immune Regulation
Wenze Zhang, Ying Liu, Zhe Zhao, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 14058-14079
Open Access
Treatment-induced ripple effect: a systematic review exploring the abscopal phenomenon in Glioblastoma multiforme
Ali Haider Bangash, Prabhat Poudel, Khalid M. Alshuqayfi, et al.
Journal of Neuro-Oncology (2024)
Closed Access
Oncolytic adenovirus H101 enhanced antitumor effects of PD-1 blockade by downregulating CD47 on tumor cells
Chenxiao Qiao, Song Wang, Yipeng Xu, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Intranasal Delivery of the Oncolytic Adenovirus XVir-N-31 via Optimized Shuttle Cells Significantly Extends the Survival of Glioblastoma Bearing Mice
Ali El-Ayoubi, Moritz Klawitter, Jakob Rüttinger, et al.
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top